ReviewCells2021
Cell Line Models for Acquired Resistance to First-Line Osimertinib in Lung Cancers-Applications and Limitations.
Shuta Ohara et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papercites it
ReviewCells2021
Shuta Ohara et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.